MD Anderson Cancer Center Madrid – Hospiten goes pink Published on 16/10/2019 Breast Cancer Awareness Day is Saturday, 19 October, but the MD Anderson Cancer Center Madrid – Hospiten is getting an early start. Today, Tuesday, 15 October, it’s joining the challenge of raising awareness and helping to prevent breast cancer, which affects over 35,000 women every year in our country.
Social networks and the Internet rack up hundreds of falsehoods about breast cancer Published on 16/10/2019 Each year over 32,500 women in Spain are diagnosed with breast cancer, according to figures from the Spanish Medical Oncology Society (Sociedad Española de Oncología Médica, or SEOM), and most of them will turn to social networks and the Internet for more information after their diagnosis.
A combination of chemotherapy and immunotherapy for the first time shows superiority over chemotherapy alone in metastatic bladder cancer Published on 08/10/2019 Dr. Enrique Grande, head of the Medical Oncology Service at MD Anderson Madrid – Hospiten, is co-chair of the IMvigor130 clinical trial, which has evaluated the efficacy of this combination in front line treatment
IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)
The MD Anderson Cancer Center Madrid – Hospiten wins a BSH award in the kidney and urinary tracts category Published on 26/09/2019 Madrid, 26 September 2019. The MD Anderson Cancer Center Madrid – Hospiten has won a BSH–Best Spanish Hospitals award in the kidney and urinary tracts category. Doctor Santiago González, medical director of MD Anderson Madrid – Hospiten, and Doctor Maria Luisa Baleztena, coordinator of healthcare coding at Hospiten, were honoured with collecting the award.
MD Anderson Cancer Center Madrid – Hospiten launches a platform to predict toxicity of chemotherapy Published on 20/09/2019 The analysis of these results, easily obtainable through a simple blood sample, allows the healthcare professional to adjust the doses or opt for other treatments that are less toxic for the patient
One in three patients on immunotherapy treatment has adverse effects involving the digestive system Published on 16/09/2019 MD Anderson Cancer Center Madrid – Hospiten experts advise the inclusion of specific recommendations at the nutritional level in these patients to avoid malnutrition, according to the conclusions of their research in more than 300 subjects
Vaccination for human papillomavirus in male children, essential to eradicate cervical cancer in women Published on 20/08/2019 80% of women have had contact with HPV, although most of them build immunity against the virus and eliminate it naturally
Direct exposure to airflow from air conditioning can cause respiratory infections in cancer patients Published on 20/08/2019 The aim of the guidelines is to help patients live as normal a life as possible, making travel easier and minimizing problems caused by their illness
Dr. Ricardo Cubedo, new head of Sarcomas and Hereditary Cancer at MD Anderson Cancer Center Madrid – Hospiten Published on 16/07/2019 Dr. Cubedo is a member of the Spanish Breast Cancer Research Group (GEICAM) and Sarcomas (GEIS), as well as a designated expert with the European Medicines Agency (EMA), among other leading positions